Khan Alina, Itrat Ahmed
North East Ohio Medical University, Rootstown, Ohio.
North East Ohio Medical University, Rootstown, Ohio; Cleveland Clinic Akron General Medical Center, Akron, Ohio.
J Stroke Cerebrovasc Dis. 2018 Mar;27(3):e48-e49. doi: 10.1016/j.jstrokecerebrovasdis.2017.09.066. Epub 2017 Oct 31.
We report a patient who had recurrence of stroke in the basilar artery territory because of repeat thrombosis, and was administered intravenous recombinant tissue plasminogen activator (IV-rtPA) twice within a span of 3 weeks without any adverse events, with radiological evidence of successful thrombolysis. Because of minor and improving stroke symptoms with IV-rtPA, endovascular therapy was not performed and there was radiological evidence of recanalization with IV-rtPA alone. This report adds to the very limited literature on the topic demonstrating safe and successful use of repeat IV thrombolysis following a previous recent stroke.
我们报告了一名患者,其基底动脉区域因再次血栓形成而发生中风复发,并在3周内两次接受静脉注射重组组织型纤溶酶原激活剂(IV-rtPA)治疗,未出现任何不良事件,且有放射学证据表明溶栓成功。由于使用IV-rtPA后中风症状轻微且有所改善,因此未进行血管内治疗,且仅有IV-rtPA治疗实现再通的放射学证据。本报告补充了关于该主题的非常有限的文献,证明了近期中风后重复静脉溶栓的安全和成功使用。